These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20806416)

  • 41. LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitors.
    Keller C; Grützmacher P; Bahr F; Schwarzbeck A; Kroon AA; Kiral A
    Lancet; 1993 Jan; 341(8836):60-1. PubMed ID: 8093314
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of symptomatic HyperLp(a)lipoproteinemia with LDL-apheresis: a multicentre study.
    Stefanutti C; D'Alessandri G; Russi G; De Silvestro G; Zenti MG; Marson P; Belotherkovsky D; Vivenzio A; Di Giacomo S
    Atheroscler Suppl; 2009 Dec; 10(5):89-94. PubMed ID: 20129383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [LDL apheresis].
    Homma Y
    Nihon Rinsho; 2004 May; 62 Suppl 5():590-4. PubMed ID: 15197990
    [No Abstract]   [Full Text] [Related]  

  • 44. ACE inhibitors and LDL-apheresis with dextran sulphate adsorption.
    Kroon AA; Mol MJ; Stalenhoef AF
    Lancet; 1992 Dec; 340(8833):1476. PubMed ID: 1360599
    [No Abstract]   [Full Text] [Related]  

  • 45. Differential effects of lipoprotein apheresis by lipidfiltration or dextran sulfate adsorption on lipidomic profile.
    Gräßler J; Kopprasch S; Passauer J; Fischer S; Schuhmann K; Bergmann S; Siegert G; Shevchenko A; Bornstein SR; Julius U
    Atheroscler Suppl; 2013 Jan; 14(1):151-5. PubMed ID: 23357157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of lipoprotein(a) in clotting reactions during lipoprotein apheresis--A case report.
    Matney K; Berg M; Falko JM; Draper NL
    J Clin Lipidol; 2016; 10(2):438-42. PubMed ID: 27055976
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipoprotein apheresis reduces circulating galectin-3 in humans.
    Eliaz I; Weil E; Dutton JA; McCalley AE; Nolte B; Moriarty PM
    J Clin Apher; 2016 Aug; 31(4):388-92. PubMed ID: 26126949
    [TBL] [Abstract][Full Text] [Related]  

  • 48. LDL apheresis in atherosclerotic disease with hyperlipidemia.
    Naganuma S; Agishi T; Ota K
    ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remission of a refractory nephrotic syndrome after low-density lipoprotein apheresis based on dextrane sulphate adsorption.
    Faucher C; Albert C; Beaufils H; Jouanneau C; Dupouet L
    Nephrol Dial Transplant; 1997 May; 12(5):1037-9. PubMed ID: 9175066
    [No Abstract]   [Full Text] [Related]  

  • 50. Low-density lipoprotein apheresis and changes in plasma components.
    Kojima S
    Ther Apher; 2001 Aug; 5(4):232-8. PubMed ID: 11724506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
    Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
    Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lipid apheresis techniques: current status in Germany.
    Grützmacher P; Kleinert C
    Clin Res Cardiol Suppl; 2012 Jun; 7(Suppl 1):20-3. PubMed ID: 22911177
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low density lipoprotein hemoperfusion by direct adsorption of lipoproteins from whole blood (DALI apheresis): clinical experience from a single center.
    Bosch T; Lennertz A; Kordes B; Samtleben W
    Ther Apher; 1999 Aug; 3(3):209-13. PubMed ID: 10427617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lowering Low-Density Lipoprotein Particles in Plasma Using Dextran Sulphate Co-Precipitates Procoagulant Extracellular Vesicles.
    Wang JW; Zhang YN; Sze SK; van de Weg SM; Vernooij F; Schoneveld AH; Tan SH; Versteeg HH; Timmers L; Lam CSP; de Kleijn DPV
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29286309
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anion-blood contact reaction (ABC reaction) in patients treated by LDL apheresis with dextran sulfate-cellulose column while receiving ACE inhibitors.
    Agishi T
    JAMA; 1994 Jan; 271(3):195-6. PubMed ID: 7695665
    [No Abstract]   [Full Text] [Related]  

  • 56. LDL-apheresis: technical and clinical aspects.
    Bambauer R; Bambauer C; Lehmann B; Latza R; Schiel R
    ScientificWorldJournal; 2012; 2012():314283. PubMed ID: 22654591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma constituents other than low-density lipoprotein adsorbed by dextran-sulfate column.
    Kojima S; Harada-Shiba M; Yamamoto A
    Ther Apher; 1997 Nov; 1(4):309-13. PubMed ID: 10225721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
    Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
    Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-induced extracorporeal low-density lipoprotein precipitation and low-density lipoprotein chemoadsorption onto dextran sulfate: a comparison.
    Bosch Y
    Artif Organs; 1996 Apr; 20(4):328-31. PubMed ID: 9139618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dextran sulfate-cellulose adsorption in the management of a myeloma patient with renal amyloidosis.
    Taniguchi Y; Yorioka N; Kumagai J; Ogata S; Sakikubo E; Yamakido M
    Int J Artif Organs; 1999 May; 22(5):349-50. PubMed ID: 10467936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.